CompletedNCT01806779
Bupropion and Varenicline Together for Smoking Cessation
About this title
Read the official source — NCT01806779Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Charlotte and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateMarch 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 376
- Sponsor
- Duke University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01806779
- Official title
Show the full official title
Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Charlotte · Durham · Raleigh
1 more locations
- Winston-Salem
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Duke University, a university.
Did this study involve medication?
Yes. The study involved medication, including Chantix, Zyban and Nicotine patches.
Who was this study for?
Listed age limits: 18 years to 65 years.
